RVTYREVVITY, INC.
Laboratory Analytical Instruments
- Revenue
- $2.9B
- 3.7% YoY
- Operating margin
- 12.5%
- 0.8% YoY
- EBITDA
- $762M
- 1.6% YoY
- Market cap
- —
- Employees
- —
- Net debt / EBITDA
- 2.9×
- $2.2B net debt
- AI in 10-K
- —
Red flags 2 of 9
- TSR below peersClear—3+ of last 5 years
- High CEO pay despite TSRClear—Median CEO pay ≥ $15M and TSR flag
- Active 13DClear0 filingsActive-intent 13D in 18 months
- Net insider sellingClear$0 netNet sales over $10M in 12 months
- Earnings not backed by cashClear242% of net incomeCash flow under 80% of net income
- Dilutive SBCClear1% of revenueOver 10% of revenue
- Payouts exceed cash flowFired146% of cash flowBuybacks + dividends over cash flow
- Goodwill-heavyFired55% of assetsOver 40% of assets
- Shareholder dissentClear—Any vote under 80% support
Financials
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | YoY |
|---|---|---|---|---|---|---|
| Revenue | $2.7B | $3.8B | $2.8B | $2.8B | $2.9B | 3.7% |
| Operating income | $867M | $1.3B | $301M | $347M | $357M | 2.9% |
| Net income | $728M | $943M | $693M | $270M | $241M | 11% |
| Operating cash flow | $892M | $1.4B | $91M | $628M | $583M | 7.2% |
| Capex | $64M | $86M | $81M | $87M | $74M | 15% |
| Stock-based comp | $27M | $30M | $41M | $38M | $23M | 40% |
| Buybacks | $7M | $73M | $389M | $370M | $821M | 122% |
| Dividends | $31M | $32M | $35M | $34M | $33M | 4.8% |
Deal filings
None.
13D filers
None on file.
Insider trading
- Open-market buys, 12 mo
- $0 · 0
- Open-market sells, 12 mo
- $1M · 4
- Net
- −$1M
Pay vs performance
No pay-versus-performance disclosure yet.